The conditions of the international tournament which is part of Japan’s „Robot New Strategy“ will be announced in 2016, a pre-torunament will be held in 2018, and the finals are due in 2020. NEDO news release, December 25, 2015
Five clinical studies will include diabetes-related stem-cell transplantations, treatment of severe familial hypercholesterolemia and hematopoietic stem-cell transplantation for the treatment of drug-resistant CMV. The studies will be done at Fukushima Medical...
The public-private partnership which is supported by 22 companies, NAIST, RIKEN and many universities will organize a collaborative screening consortium (drug-discovery innovation and screening consortium, DISC) based on 200,000 compounds from these companies. One...
A group at RIKEN found through experiments on Arabidopsis thaliana that Ky-2, a histone deacetylase inhibitor, enhanced high-salinity stress tolerance in this plant. Ky-2 activates the transcription of AtSOS1, a sodium antiporter, by increasing histone acetylation doi...
Partner is Anikom Holdings, Japan’s largest pet insurance with links to 6000 animal hospitals in Japan. Business targets are the development and provision of cell treatment (heterologous or autologous) of fractures, diabetes etc. Fujifilm holds 51 % of the JV, and...
